Q3 2024 Holdings
Filed 2024-11-12 | 36 holdings | $212.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $27.1M | 30,564 | 12.7% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $20.8M | 35,490 | 9.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $17.6M | 154,699 | 8.3% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $13.6M | 22,012 | 6.4% |
| Amgen Inc(AMGN) | COM | 031162100 | $9.3M | 28,965 | 4.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $8.9M | 106,172 | 4.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $8.8M | 44,486 | 4.1% |
| Stryker Corporation(SYK) | COM | 863667101 | $8.5M | 23,460 | 4.0% |
| Cencora Inc(COR) | COM | 03073E105 | $8.2M | 36,544 | 3.9% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.9M | 16,993 | 3.7% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.4M | 7,028 | 3.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.0M | 60,607 | 3.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.6M | 236,610 | 3.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $6.2M | 84,578 | 2.9% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $6.1M | 151,875 | 2.9% |
| UFP Technologies Inc(UFPT) | COM | 902673102 | $5.7M | 18,048 | 2.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.4M | 138,321 | 2.5% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.6M | 53,757 | 1.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $3.4M | 40,230 | 1.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.3M | 82,691 | 1.6% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $3.0M | 27,500 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.9M | 275,472 | 1.4% |
| Merus N V | COM | N5749R100 | $2.5M | 50,687 | 1.2% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $2.4M | 36,505 | 1.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $2.3M | 138,983 | 1.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $1.9M | 86,013 | 0.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $1.7M | 54,060 | 0.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $1.7M | 9,202 | 0.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.6M | 442,423 | 0.8% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $1.4M | 69,573 | 0.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.4M | 53,432 | 0.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $1.3M | 26,390 | 0.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.0M | 538,621 | 0.5% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $822.0K | 200,000 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $795.4K | 168,522 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $635.8K | 34,328 | 0.3% |